![Meriam Kabbaj](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Meriam Kabbaj
Direttore Tecnico/Scientifico/R&S presso GENFIT
Profilo
Meriam Kabbaj has founded Versantis AG in 2015, where she holds the title of Chief Operating Officer & Director.
She is currently the Chief Technology Officer at Genfit SA since 2022.
Dr. Kabbaj has a doctorate degree from the University of Montréal.
Posizioni attive di Meriam Kabbaj
Società | Posizione | Inizio |
---|---|---|
GENFIT | Direttore Tecnico/Scientifico/R&S | 01/12/2022 |
Versantis AG
![]() Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Fondatore | 01/01/2015 |
Formazione di Meriam Kabbaj
University of Montréal | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
GENFIT | Health Technology |
Aziende private | 1 |
---|---|
Versantis AG
![]() Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Meriam Kabbaj